Obesity Drugs Enjoy a Much-Needed Winning Str...

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.Stocks and bonds slipped along with gold and silver on the last day of 2025, bringing a subdued close to an otherwise buoyant year across asset classes that saw US equities post their third straight double-digit ...  عرض المزيد

Bitcoin briefly topped the $90,000 mark on Monday before erasing gains, leaving traders waiting on a potential breakout after the token missed a Santa rally that sent stocks to record highs. Other cryptocurrencies had also swung, with Ether up as much as 4% to surpass $3,000 befo ...  عرض المزيد

Bloomberg Opinion Columnist and Former New York Fed President William Dudley discusses the outlook for the labor market and Fed monetary policy. David Riley, BlueBay Asset Management Chief Investment Strategist, says the market is underpricing the Fed. Danny Blanchflower, Dartmou ...  عرض المزيد

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  عرض المزيد

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  عرض المزيد

One of the most iconic brands in financial television returns for today's issues and today's world. This week's Wall Street Week features David Westin's interviews with Former Council of Economic Advisers Chairman Glenn Hubbard, Equity Group Investments Founder & Chairman Sam Zel ...  عرض المزيد